Online citations, reference lists, and bibliographies.
← Back to Search

Neutrophil Extracellular Traps In Inflammatory Disorders

C. S. Chowdhury
Published 2014 · Biology

Cite This
Download PDF
Analyze on Scholarcy
A novel feature of polymorphonuclear granulocyte (PMN) biology is their ability to generate neutrophil extracellular traps (NETs) via a distinct process of cell death termed NETosis. NETs consist of chromosomal extruded DNA decorated with granular components that include antimicrobial peptides and proteases. The molecular pathways leading to NETosis involve generation of reactive oxygen species (ROS), calcium mobilization, nuclear delobulation involving the enzymatic activities of myeloperoxidase (MPO) and neutrophil elastase (NE), and chromatin modification via the citrullination of histones by peptidyl arginine deiminase 4 (PAD4). A number of studies have implicated NETs in the etiology of auto-inflammatory or autoimmune conditions such as preeclampsia (PE), Felty’s syndrome, systemic lupus erythematosus (SLE), multiple sclerosis (MS), and, most recently, rheumatoid arthritis (RA). In the context of RA these findings are especially interesting, as NETs have been proposed to contribute to the generation of anti-citrullinated protein antibody (ACPA) auto-antigens, and may also be a target for autoantibodies. As we have previously detected significantly increased concentrations of cell-free DNA in the sera of RA patients compared with healthy controls, we were intrigued whether the elevation in this material involved NETosis. The premise for this investigation was that a link between circulating cell-free DNA levels and NETs has previously been made in a number of conditions including preeclampsia, sepsis, cancer, thrombosis or even storage of blood transfusion products. In view of these findings and reports on the complex involvement of neutrophil NETs in autoimmunity, we sought to investigate the NETotic response of PMN in RA, with particular regard to the underlying signal transduction cascade, and whether the products of overt NETosis could be diagnostically useful. Our data confirm and extend upon these observations in that we examined for changes in the underlying signal transduction cascade required for the induction of NETosis. These findings indicate that the propensity of circulatory PMN in RA patients to undergo NETosis is associated with elevations in members of this cascade including increased intracellular ROS production, enhanced expression of NE and MPO, and increased nuclear translocation of PAD4 and citrullination of histones, notably H3. Furthermore, by examining kinetic changes during extended in vitro culture it was observed that PMN from RA cases exhibited different nuclear morphometric characteristics, having a lower proportion of the classical lobulated phenotype. In the presence of a secondary stimuli, RA PMN also progressed more rapidly and extensively to a NETotic spread phenotype than controls, a finding confirmed by analysis of culture supernatants for the products of NETosis. Akin to what has been observed in an array of other pathological conditions ranging from SLE to cancer, PMN from RA patients exhibited an increased response to further stimulation. This response is in part mediated via the action of PAD4, as the effect of PMA could be significantly reduced by treatment with Cl-amidine, an inhibitor of PAD4. In addition, PMA treatment lead to an increased nuclear presence of this enzyme, where it presumably could be able to carry out a more extensive citrullination of histone proteins, thereby speeding up the induction of NETosis. A very intriguing and novel feature of our data is the detection of the extracellular presence of PAD4 on extruded NETs. The concomitant extracellular presence of this enzyme on NETs may increase the spectrum of citrullinated proteins and their local concentration significantly, a feature which could be important in the generation of ACPA. It is furthermore possible that the extracellular localisation of PAD4 may play a role in the development of anti-PAD4 antibodies observed in cases with RA. Hence, our data support and extend upon recent reports indicating that NETs can be a source for citrullinated autoantigens, or react with ACPA. Further presence of NETs in the intervillous space of preeclamptic placenta was previously reported by our lab. Using in vitro experiments, we have shown that trophoblast micro-debris could stimulate neutrophils to form NETs. However the effect of such phenomena remained elusive. Recent data suggests, NETs could act as a lattice, to stimulate platelet adhesion, promotes coagulation and thrombotic events. Given that PE, intrauterine growth restriction (IUGR) and even fetal loss are broadly related to elevated thrombotic events causing dysfunctions at the interface between innate immunity and haemostasis, it is of cardinal importance to investigate whether NETs could elucidate such a response. In this study, we adopted mice sFLT-1 overexpression model, to elucidate the impact of NETosis in murine pregnancy outcome. Preliminary results indicates significant drop in pregnancies after sFLT-1 overexpression although there was only a partial induction of PE phenotype characterized by minor elevation in blood pressure and proteinuria. Staining of placentas from mice that retained pregnancy after sFLT-1 overexpression indicates heavy neutrophil infiltration in the feto-placental junction, with zones positive for NET specific markers. Plasma isolated from sFLT-1 treated mouse also indicates elevation of NET specific markers compared to healthy pregnant controls. Minor increase in plasma TAT complexes (although not significant), along with a drop in platelet count, indicates elevated thrombotic events. Further ongoing experiments will compare the impact of sFLT-1 overexpression in normal WT mice to those that are unable to form NETs.
This paper references
Tracing the molecular pathogenesis of antiphospholipid syndrome.
H. Weiler (2008)
Framingham Risk Score to improve utilization in a primary care clinic
N Raju (2011)
Neutrophil-derived circulating free DNA (cf-DNA/NETs), a potential prognostic marker for mortality in patients with severe burn injury
J. Altrichter (2010)
[Pathophysiology and clinical manifestations in pre-eclampsia].
K. Haram (2000)
comparison with rheumatoid factor in rheumatoid arthritis
GJ Pruijn (2010)
Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)
B. Sibai (1993)
Circulating fetal DNA in maternal plasma is increased in pregnancies at high altitude and is further enhanced by preeclampsia.
X. Zhong (2004)
Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction.
F. Lyall (2001)
Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?
Z. Szekanecz (2008)
regulatory circuit to perpetuate the inflammation in rheumatoid arthritis
AP Hollander (2001)
Extracellular DNA traps promote thrombosis
T. Fuchs (2010)
Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism
I. Pabinger (2001)
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
J. Knight (2013)
extracellular trap formation by anti-inflammatory drugs
A Caudrillier (2012)
Neutrophil extracellular trap (NET) impact on deep vein thrombosis.
T. Fuchs (2012)
Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4.
F. Semeraro (2011)
Extracellular Chromatin Is an Important Mediator of Ischemic Stroke in Mice
S. D. De Meyer (2012)
Pathogens and the placental fortress.
J. Robbins (2012)
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies
J. W. Meekins (1994)
[Primary prevention of cardiovascular disease].
Tina Katić (2009)
Diagnosis and management of atypical preeclampsia-eclampsia.
B. Sibai (2009)
Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
P. Chatterjee (2012)
rheumatoid arthritis
J Shi (2011)
Rheumatoid arthritis. Pathophysiology and implications for therapy.
E. Harris (1990)
Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones
M. Saffarzadeh (2012)
Clinical use of circulating nucleosomes.
S. Holdenrieder (2009)
Neutrophil Extracellular Trap Formation: A Single Cell Event?
L. Völlger (2015)
Lymphocyte Function-Associated Antigen 1 (LFA-1)
E. Martz (1998)
citrullinated antigens
TB Niewold (2007)
Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
Maria L Miranda (2013)
The effect of leukocyte elastase on tissue factor pathway inhibitor.
D. Higuchi (1992)
Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.
P. Redecha (2009)
Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia.
A. Gupta (2005)
Histone H2B as a functionally important plasminogen receptor on macrophages.
Riku Das (2007)
ELISA and quantitative PCR
N Umetani (2006)
Diagnosis and management of pre-eclampsia: an update
J. Turner (2010)
Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
X. Y. Zhong (2001)
Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.
A. Swart (2012)
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
R. Romero (2008)
eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.
F. Li (2012)
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
S. Clark (2007)
receptor signalling-induced inflammation in rheumatoid arthritis
AM McInturff (2012)
reactive oxygen species formation and oxidative stress
D Shechter (2007)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
S. Maynard (2003)
Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study.
J. Chen (2013)
serum DNA in patients with colorectal liver metastases
M van der Vaart (2008)
Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides.
N. Tuaillon (1990)
DNA-based assembly lines and nanofactories.
F. Simmel (2012)
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.
G. Girardi (2003)
extracellular traps in transfusion-related acute lung injury
PA Monach (2010)
Maternal Preeclampsia and Neonatal Outcomes
C. Backes (2011)
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury.
A. Caudrillier (2012)
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
Pingxin Li (2010)
deiminated histones and neutrophil extracellular chromatin traps
R Lande (2011)
Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice.
Shuo Geng (2013)
Regulation of human neutrophil‐mediated cartilage proteoglycan degradation by phosphatidylinositol‐3‐kinase
C. Hii (2001)
immunity mediated by neutrophil extracellular traps
K Martinod (2013)
Mechanisms of Disease: pre-eclampsia
M. Noris (2005)
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
Y. Zhou (2002)
inducers of type I IFN production in pediatric systemic lupus erythematosus
N Dwivedi (2013)
monoglandular and polyglandular autoimmunity
M Cabrini (2010)
Thrombosis in Pregnancy: Maternal and Fetal Issues
La. Greer (1999)
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
V. Holers (2002)
The placenta in pre-eclampsia and intrauterine growth restriction
D. Roberts (2008)
Implantation and the placenta: key pieces of the development puzzle.
J. Cross (1994)
Neutrophils release extracellular DNA traps during storage of red blood cell units
T. Fuchs (2013)
Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis.
G. Frampton (1986)
D. Murphy (2000)
histone deimination in granulocytes
M Demers (2012)
What coatings layer the walls of BD Vacutainer® Plus Serum and SSTTM Tubes
H Schwarzenbach (2014)
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
S. Massberg (2010)
Netting neutrophils
GS Garcia-Romo (2011)
induced peptidylarginine deiminase 4 translocation
K Nakashima (2002)
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury.
P. Redecha (2007)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
S. Pierangeli (2005)
Hypoxia and hypoxia-inducible factor-1alpha provoke toll-like
F Hu (2013)
Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
T. Kobayashi (1987)
Free DNA – new potential analyte in clinical laboratory diagnostics?
J. Wagner (2012)
activity in patients with inflammatory bowel diseases
M Dittmar (2011)
Aspirin for primary prevention of coronary heart disease.
P. Jackson (2004)
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis.
L. Trouw (2012)
Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis.
Xiao-Yan Zhong (2007)
The major fibrinolytic proteases of human leukocytes.
E. Plow (1980)
Circulatory nucleosome levels are significantly increased in early and late‐onset preeclampsia
X. Zhong (2005)
Preeclampsia: Management and prognosis. UpToDate
ER Norwitz (2014)
DNA diagnosis for the practicing obstetrician.
G. Gupta (1997)
Neutrophil Extracellular Traps and Systemic Lupus Erythematosus.
Y. Yu (2013)
Treatment of Mice with the Neutrophil-Depleting Antibody RB6-8C5 Results in Early Development of Experimental Lyme Arthritis via the Recruitment of Gr-1− Polymorphonuclear Leukocyte-Like Cells
C. Brown (2004)
Neutrophils, but Not Lymphocytes or Monocytes, Infiltrate Maternal Systemic Vasculature in Women with Preeclampsia
K. A. Cadden (2008)
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.
N. Dwivedi (2012)
Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR.
S. Holdenrieder (2005)
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.
Fangxian Lu (2007)
arthritis target citrullinated histone 4 contained in neutrophils extracellular traps
N Wegner (2010)
Spontaneous release of DNA by human blood lymphocytes in vitro
P. Anker (1975)
Paternal and maternal components of the predisposition to preeclampsia.
K. Heyborne (2001)
The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens.
K. Egerer (2009)
Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity
E. Darrah (2013)
An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion
Lihong Pang (2013)
Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.
A. Cross (2003)
Risk factors and clinical manifestations of pre‐eclampsia
Rønnaug A. Ødegård (2000)
Putting pressure on pre-eclampsia
Samir M. Parikh (2008)
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.
S. Bustin (2009)
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.
A. Lynch (2010)
Risk of venous
ME Holmqvist (2012)
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
G. Alguel (2006)
Role of tissue factor in feto‐maternal development: a xiphos
G. Girardi (2011)
Fuchs et al Neutrophil Extracellular Trap Impact on Deep Vein Thrombosis 3
T. Fuchs
Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease
Camille E. Powe (2011)
Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire
B. Fisher (2012)
Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
M. A. Thijssen (2002)
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study
Wei-Sheng Chung (2014)
Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis‐mediated cell death
A. Gupta (2010)
Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis
E. Darrah (2012)
Parity and the risk
C Orellana (2014)
Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes
H. Knowles (2011)
Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.
A. Conde-Agudelo (1999)
Diagnosis, prevention, and management of eclampsia.
B. Sibai (2005)
information for publication of quantitative real-time PCR experiments
A Hakkim (2011)
Novel cell death program leads to neutrophil extracellular traps.
T. A. Fuchs (2007)
Neutrophil extracellular traps promote deep vein thrombosis in mice
A. Brill (2012)

Semantic Scholar Logo Some data provided by SemanticScholar